Avanos Medical, Inc.
AVNS
Jodie situation report
Avanos Medical, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 2 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 8 directly disclosed connections are confirming.
- AVNS's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if AVNS's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind AVNS
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
MCK18.0% of AVNScustomerFeb 24, 2026 ▾
“In the year ended December 31, 2024, sales to McKesson Corporation and Medline Industries accounted for approximately 18% and 17% of consolidated net sales, respectively.”
MDLN15.0% of AVNScustomerFeb 24, 2026 ▾
“In the year ended December 31, 2025, sales to Medline Industries accounted for approximately 12% of consolidated net sales.”
BSXBoston Scientific CorporationcompetitorFeb 24, 2026 ▾
“Major competitors include, among others: • Specialty Nutrition Systems: Boston Scientific Corporation, Cook Medical, Applied Medical Technology, Inc.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 11 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
AVNS is currently a Leader in the organic co-movement group Pain Management Devices. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for AVNS; it is not active in the latest market snapshot.